Galmed Pharma (GLMD) Misses Q1 EPS by 3c

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Bernstein SocGen on UnitedHealth Group (UNH): 'Expecting a strong 2Q driven by MA and potential for guidance raise'
• AeroVironment (AVAV) Tops Q4 EPS by 36c